LIU Miao, FAN Pingsheng, ZHANG Tengyue, HUANG Jin, FAN Gaofei, LIU Yabei. Role of calmodulin-dependent protein kinase Ⅱ in reversingdrug resistance to cisplatin chemotherapy by verapamil in patients with lung adenocarcinoma cells[J]. Journal of Clinical Medicine in Practice, 2019, 23(10): 5-8. DOI: 10.7619/jcmp.201910002
Citation: LIU Miao, FAN Pingsheng, ZHANG Tengyue, HUANG Jin, FAN Gaofei, LIU Yabei. Role of calmodulin-dependent protein kinase Ⅱ in reversingdrug resistance to cisplatin chemotherapy by verapamil in patients with lung adenocarcinoma cells[J]. Journal of Clinical Medicine in Practice, 2019, 23(10): 5-8. DOI: 10.7619/jcmp.201910002

Role of calmodulin-dependent protein kinase Ⅱ in reversingdrug resistance to cisplatin chemotherapy by verapamil in patients with lung adenocarcinoma cells

More Information
  • Received Date: March 09, 2019
  • Accepted Date: April 16, 2019
  • Available Online: February 22, 2021
  • Published Date: May 27, 2019
  •   Objective  To investigate the role of calmodulin-dependent protein kinase Ⅱ(CaMKⅡ) in reversing drug resistance to cisplatin chemotherapy by verapamil in patients with lung adenocarcinoma cells.
      Methods  In lung adenocarcinoma cell lines (A549), the CCK-8 method was used to detect the ability of verapamil in reversing the drug resistance to cisplatin chemotherapy, the Annexin V-FITC/PI method was used to detect the effect of verapamil on reversing the apoptosis of drug resistance to cisplatin chemotherapy, and the Western blotting was used to detect the expression levels of P-CaMKⅡ/CaMKⅡ protein in reversal process.
      Results  In the A549 cell line, the inhibition rates of DDP group and DDP-VER combination group were (55.00±2.60) % and (32.30±1.80) % respectively, and there was significant difference between the two groups (P < 0.05). The apoptosis rates of DDP group and DDP-VRP combination group were 10.30% and 21.60% respectively, and there was significant difference between the two groups (P < 0.05). Western blotting results showed that the expression level of P-CaMKⅡ/CaMKⅡ protein in A549 cell line in DDP-VRP combination group was obviously lower than that in DDP group.
      Conclusion  In lung adenocarcinoma cells, CaMKⅡ participates in the reversal process of drug resistance to cisplatin chemotherapy by verapamil.
  • [1]
    Siegel R L, Miller K D, Jemal A. Cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(1): 7-30. doi: 10.3322/caac.21442
    [2]
    刘其秀, 樊高飞, 吴旸, 等. 靶动脉灌注维拉帕米和化疗药物治疗非小细胞肺癌的临床研究[J]. 肿瘤学杂志, 2016, 22(11): 957-961. doi: 10.11735/j.issn.1671-170X.2016.11.B017
    [3]
    滕小路, 刘淼, 张腾跃, 等. 维拉帕米通过调节Bcl-2表达对胃癌细胞株耐阿霉素的影响[J]. 肿瘤学杂志, 2018, 24(4): 328-335. https://www.cnki.com.cn/Article/CJFDTOTAL-XHON201804010.htm
    [4]
    Zhang T Y, Ma K L, Huang J, et al. CDKN2B is critical for verapamil-mediated reversal of doxorubicin resistance in hepatocellular carcinoma[J]. Oncotarget, 2017, 8(66): 110052-110063. doi: 10.18632/oncotarget.22123
    [5]
    Zhang D X, Fan D M. New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives[J]. Future Oncol, 2010, 6(4): 527-537. doi: 10.2217/fon.10.21
    [6]
    Fan P S, Zhang T Y, Huang Q, et al. Basic and clinical research on the therapeutic effect of intervention in primary liver cancer by targeted intra-arterial verapamil infusion[J]. Cell Biochem Biophys, 2012, 62(1): 59-67. doi: 10.1007/s12013-011-9259-4
    [7]
    Huang J, Duan Q H, Fan P S, et al. Clinical evaluation of targeted arterial infusion of verapamil in the interventional chemotherapy of primary hepatocellular carcinoma[J]. Cell Biochem Biophys, 2011, 59(2): 127-132. doi: 10.1007/s12013-010-9125-9
    [8]
    Liu Y, Lu Z, Fan P, et al. Clinical efficacy of chemotherapy combined with verapamil in metastatic colorectal patients[J]. Cell Biochem Biophys, 2011, 61(2): 393-398. doi: 10.1007/s12013-011-9198-0
    [9]
    Ly P T, Song W H. Loss of activated CaMKⅡ at the synapse underlies Alzheimer′s disease memory loss[J]. J Neurochem, 2011, 119(4): 673-675. doi: 10.1111/j.1471-4159.2011.07473.x
    [10]
    McGargill M A, Sharp L L, Bui J D, et al. Active Ca2+/calmodulin-dependent protein kinase Ⅱ gamma B impairs positive selection of T cells by modulating TCR signaling[J]. J Immunol, 2005, 175(2): 656-664. doi: 10.4049/jimmunol.175.2.656
    [11]
    Bers D M. CaMKⅡ inhibition in heart failure makes jump to human[J]. Circ Res, 2010, 107(9): 1044-1046. doi: 10.1161/CIRCRESAHA.110.231902
    [12]
    Britschgi A, Bill A, Brinkhaus H, et al. Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling[J]. Proc Natl Acad Sci USA, 2013, 110(11): E1026-E1034. doi: 10.1073/pnas.1217072110
    [13]
    Lisman J, Yasuda R, Raghavachari S. Mechanisms of CaMKⅡ action in long-term potentiation[J]. Nat Rev Neurosci, 2012, 13(3): 169-182. doi: 10.1038/nrn3192
    [14]
    Chai S J, Qian Y Y, Tang J F, et al. RETRACTED: Ca2+/calmodulin-dependent protein kinase Ⅱγ, a critical mediator of the NF-κB network, is a novel therapeutic target in non-small cell lung cancer[J]. Cancer Letters, 2014, 344(1): 119-128. doi: 10.1016/j.canlet.2013.10.022
    [15]
    Liu Z L, Han G, Cao Y, et al. Calcium/calmodulin dependent protein kinase Ⅱ enhances metastasis of human gastric cancer by upregulating nuclear factor-κB and Akt-mediated matrix metalloproteinase-9 production[J]. Mol Med Rep, 2014, 10(5): 2459-2464. doi: 10.3892/mmr.2014.2525
    [16]
    Meng Z P, Li T, Ma X X, et al. Berbamine inhibits the growth of liver cancer cells and cancer-initiating cells by targeting Ca2+/calmodulin-dependent protein kinase Ⅱ[J]. Mol Cancer Ther, 2013, 12(10): 2067-2077. doi: 10.1158/1535-7163.MCT-13-0314
    [17]
    Chi M N, Evans H, Gilchrist J, et al. Phosphorylation of calcium/calmodulin-stimulated protein kinase Ⅱ at T286 enhances invasion and migration of human breast cancer cells[J]. Sci Rep, 2016, 6: 33132-33139. doi: 10.1038/srep33132
    [18]
    Chai S J, Xu X, Wang Y F, et al. Ca2+/calmodulin-dependent protein kinase Ⅱγ enhances stem-like traits and tumorigenicity of lung cancer cells[J]. Oncotarget, 2015, 6(18): 16069-16083. doi: 10.18632/oncotarget.3866
    [19]
    Gu Y, Chen T, Meng Z, et al. CaMKⅡ, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine[J]. Blood, 2012, 120(24): 4829-4839. doi: 10.1182/blood-2012-06-434894
  • Related Articles

    [1]FANG Ying, ZHOU Cunrong, LU Zhibin, XIAO Zhichao, PAN Chunfeng. Application of nursing intervention based on information-motivation-behavioral skill model in CT-guided localization of patients with isolated pulmonary nodules[J]. Journal of Clinical Medicine in Practice, 2023, 27(12): 98-104. DOI: 10.7619/jcmp.20223201
    [2]ZHANG Liaoshen, RUAN Jie. Clinical significance of chest CT signs in diagnosis of heart failure[J]. Journal of Clinical Medicine in Practice, 2020, 24(6): 34-36. DOI: 10.7619/jcmp.202006009
    [3]MEI Xia, WANG Litong. Value of CT vascular signs of lung ground-glass nodule in differential diagnosis of pathologic subtypes of lung adenocarcinoma[J]. Journal of Clinical Medicine in Practice, 2020, 24(3): 22-25. DOI: 10.7619/jcmp.202003007
    [4]CHEN Jijun, LIU Jian, FAN Feifei, MO Fei, ZHAO Xinchun, ZHAO Peng, HAO Yuewen. MRI manifestations and pathological basis of atypical meningioma[J]. Journal of Clinical Medicine in Practice, 2019, 23(17): 69-71. DOI: 10.7619/jcmp.201917019
    [5]LIU Shu, HUAN Jing, SHE Yuanxia. Correlation analysis between pathological grading of ground-glass nodules and high resolution CT signs[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 56-59. DOI: 10.7619/jcmp.201907015
    [6]TU Yi, LIANG Zuotang. High-resolution CT manifestation and pathological analysis of different types of lung adenocarcinoma[J]. Journal of Clinical Medicine in Practice, 2017, (24): 6-9. DOI: 10.7619/jcmp.201724002
    [7]ZHANG Zhilin, SONG Xiao, TANG Jianhua, CUI Shujun, ZOU Dianjun, ZHU Xiaolong, GENG Hequn. CT imaging features of renal cell carcinoma and its pathological features[J]. Journal of Clinical Medicine in Practice, 2016, (7): 82-85. DOI: 10.7619/jcmp.201607024
    [8]LIU Xianming. Clinical pathological features of young patients with breast cancer[J]. Journal of Clinical Medicine in Practice, 2015, (15): 191-193. DOI: 10.7619/jcmp.201515067
    [9]CHEN Jun, YANG Jian, YANG Fei. Analysis in clinical and pathologic features of gastric in 67 children with bile reflux gastritis[J]. Journal of Clinical Medicine in Practice, 2014, (13): 159-162. DOI: 10.7619/jcmp.201413056
    [10]CHEN Xiongdou, LIU Xin, LIN Hanfeng. Comparative study of radiological and pathological findings of neuroendocrine tumors in pancreas[J]. Journal of Clinical Medicine in Practice, 2014, (7): 161-163. DOI: 10.7619/jcmp.201407058

Catalog

    Article views (304) PDF downloads (8) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return